The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Vitamin D Repletion in Patients with Primary Hyperparathyroidism and Coexistent Vitamin D Insufficiency
Abstract
Vitamin D insufficiency is common in patients with primary hyperparathyroidism (PHPT) and may be associated with more severe and progressive disease. Uncertainty exists, however, as to whether repletion of vitamin D should be undertaken in patients with PHPT. Here we report the effects of vitamin D repletion on biochemical outcomes over 1 yr in a group of 21 patients with mild PHPT [serum calcium <12 mg/dl (3 mmol/liter)] and coexistent vitamin D insufficiency [serum 25 hydroxyvitamin D [25(OH)D] <20 μg/liter (50 nmol/liter)]. In response to vitamin D repletion to a serum 25(OH)D level greater than 20 μg/liter (50 nmol/liter), mean levels of serum calcium and phosphate did not change, and serum calcium did not exceed 12 mg/dl (3 mmol/liter) in any patient. Levels of intact PTH fell by 24% at 6 months (P < 0.01) and 26% at 12 months (P < 0.01). There was an inverse relationship between the change in serum 25(OH)D and that in intact PTH (r = −0.43, P = 0.056). At 12 months, total serum alkaline phosphatase was significantly lower, and urine N-telopeptides tended to be lower than baseline values (P = 0.02 and 0.13, respectively). In two patients, 24-h urinary calcium excretion rose to exceed 400 mg/d, but the group mean 24-h urinary calcium excretion did not change. These preliminary data suggest that vitamin D repletion in patients with PHPT does not exacerbate hypercalcemia and may decrease levels of PTH and bone turnover. Some patients with PHPT may experience an increase in urinary calcium excretion after vitamin D repletion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of Vitamin D on Falls: A Meta-analysis
Bischoff-Ferrari, H. A., Dawson-Hughes, B., Willett, W. C., Staehelin, H. B., Bazemore, M. G., Zee, R. Y., & Wong, J. B. (2004) · JAMA · doi:10.1001/jama.291.16.1999 · Cited by 1,324
Bilezikian, J. P., Potts, J. T., Fuleihan, G. E.-H., Kleerekoper, M., Neer, R., Peacock, M., Rastad, J., Silverberg, S. J., Udelsman, R., & Wells, S. A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021370 · Cited by 770
Lips, P. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.3.1212 · Cited by 711
A 10-Year Prospective Study of Primary Hyperparathyroidism with or without Parathyroid Surgery
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001133420221 · Cited by 685
Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women
Chapuy, M. C., Arlot, M. E., Delmans, P. D., & Meunier, P. J. (1994) · BMJ · doi:10.1136/bmj.308.6936.1081 · Cited by 673
Epidemiology of primary hyperparathyroidism in Europe.
Adami, S., Marcocci, C., & Gatti, D. (2002) · PubMed · Cited by 308
Wermers, R. A., Khosla, S., Atkinson, E. J., Hodgson, S. F., O'Fallon, W. M., & Melton III, L. J. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-6-199703150-00003 · Cited by 300
Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism
Silverberg, S. J., Locker, F. G., Jacobs, T. P., Shane, E. J., Siris, E. S., Staron, R. B., McMahon, D. J., & Bilezikian, J. P. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.3.7883824 · Cited by 275
The effects of vitamin D insufficiency in patients with primary hyperparathyroidism
Silverberg, S. J., Shane, E., Dempster, D. W., & Bilezikian, J. P. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00294-6 · Cited by 254
Sunlight “D”ilemma: risk of skin cancer or bone disease and muscle weakness
Holick, M. F. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03560-1 · Cited by 198
The role of 1,25‐dihydroxyvitamin D in the mechanism of acquired vitamin D deficiency
Clements, M. R., Davies, M., Hayes, M. E., Hlckey, C. D., Lumb, G. A., Mawer, E. B., & Adams, P. H. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02278.x · Cited by 192
25-Hydroxyvitamin D3-1α-Hydroxylase Expression in Normal and Pathological Parathyroid Glands
Segersten, U., Correa, P., Hewison, M., Hellman, P., Dralle, H., Carling, T., Åkerström, G., & Westin, G. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.6.8604 · Cited by 179
Guo, C. Y. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.10.3487 · Cited by 159
Metabolic inactivation of vitamin D is enhanced in primary hyperparathyroidism
Clements, M. R., Davies, M., Fraser, D. R., Lumb, G. A., Mawer, E. B., & ADAMS, P. H. (1987) · Clinical Science · doi:10.1042/cs0730659 · Cited by 149
Lumb, G. A., & Stanbury, S. (1974) · The American Journal of Medicine · doi:10.1016/0002-9343(74)90812-2 · Cited by 138
Carling, T., Rastad, J., Szabó, E., Westin, G., & Åkerström, G. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.5.2000 · Cited by 112
Davies, M., Heys, S. E., Selby, P. L., Berry, J., & Mawer, E. B. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.1.3644 · Cited by 108
Davies, M. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.1.209 · Cited by 73
Correa, P., Segersten, U., Hellman, P., Åkerström, G., & Westin, G. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021356 · Cited by 60
Accelerated bone loss in post‐menopausal women with mild primary hyperparathyroidism
Grey, A. B., Stapleton, J. P., Evans, M. C., et al. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.744565.x · Cited by 55
Self-citationVitamin D, parathyroid hormone, and calcium: a complex regulatory network
Feldman, D. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00283-1 · Cited by 37
Treatment with active vitamin D (alphacalcidol) in patients with mild primary hyperparathyroidism
Lind, L., Wengle, B., Sørensen, O. H., et al. (1989) · European Journal of Endocrinology · doi:10.1530/acta.0.1200250 · Cited by 18
Cited by
Holick, M. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmra070553 · Cited by 13,720
Holick, M. F., Binkley, N. C., Bischoff-Ferrari, H. A., Gordon, C. M., Hanley, D. A., Heaney, R. P., Murad, M. H., & Weaver, C. M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0385 · Cited by 10,538
Bilezikian, J. P., Khan, A. A., & Potts, J. T. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1763 · Cited by 1,521
Bilezikian, J. P., Brandi, M. L., Eastell, R., Silverberg, S. J., Udelsman, R., Marcocci, C., & Potts, J. T. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1413 · Cited by 1,271
Silverberg, S. J., Lewiecki, E. M., Mosekilde, L., Peacock, M., & Rubin, M. R. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1760 · Cited by 688
Metadata
- Authors
- Grey, A., Lucas, J., Horne, A., Gamble, G., Davidson, J. S., & Reid, I. R.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-04-01
- Volume
- 90
- Issue
- 4
- Pages
- 2122-2126
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2031450649
- Cited by
- 264
- References
- 22
- FWCI
- 7.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.